AIRLINK 172.90 Decreased By ▼ -2.83 (-1.61%)
BOP 13.22 Increased By ▲ 0.10 (0.76%)
CNERGY 7.42 Decreased By ▼ -0.12 (-1.59%)
FCCL 43.40 Decreased By ▼ -0.51 (-1.16%)
FFL 14.93 Decreased By ▼ -0.08 (-0.53%)
FLYNG 26.50 Decreased By ▼ -0.40 (-1.49%)
HUBC 129.41 Decreased By ▼ -0.82 (-0.63%)
HUMNL 13.30 Decreased By ▼ -0.04 (-0.3%)
KEL 4.45 Decreased By ▼ -0.05 (-1.11%)
KOSM 6.00 Decreased By ▼ -0.06 (-0.99%)
MLCF 55.40 Decreased By ▼ -0.63 (-1.12%)
OGDC 213.22 Decreased By ▼ -1.55 (-0.72%)
PACE 5.89 Decreased By ▼ -0.09 (-1.51%)
PAEL 41.15 Increased By ▲ 0.25 (0.61%)
PIAHCLA 16.61 Increased By ▲ 0.29 (1.78%)
PIBTL 9.58 Decreased By ▼ -0.17 (-1.74%)
POWER 11.54 Decreased By ▼ -0.22 (-1.87%)
PPL 179.00 Decreased By ▼ -2.48 (-1.37%)
PRL 33.70 Decreased By ▼ -0.52 (-1.52%)
PTC 22.85 Decreased By ▼ -0.21 (-0.91%)
SEARL 94.20 Decreased By ▼ -1.52 (-1.59%)
SILK 1.17 Increased By ▲ 0.03 (2.63%)
SSGC 35.00 Decreased By ▼ -0.45 (-1.27%)
SYM 15.71 Decreased By ▼ -0.04 (-0.25%)
TELE 7.83 Decreased By ▼ -0.04 (-0.51%)
TPLP 10.83 Decreased By ▼ -0.15 (-1.37%)
TRG 60.79 Increased By ▲ 0.29 (0.48%)
WAVESAPP 10.69 Decreased By ▼ -0.12 (-1.11%)
WTL 1.32 Decreased By ▼ -0.03 (-2.22%)
YOUW 3.80 Increased By ▲ 0.03 (0.8%)
BR100 12,047 Decreased By -6.9 (-0.06%)
BR30 36,415 Decreased By -51.5 (-0.14%)
KSE100 113,878 Decreased By -478.8 (-0.42%)
KSE30 35,109 Decreased By -237.7 (-0.67%)
World

EU to launch programme for 'second generation' Covid-19 vaccines

  • The EU Commission did not comment when contacted by AFP.
Published February 17, 2021

BRUSSELS: The EU will launch a programme to study Covid-19 variants and produce "second generation" vaccines against future strains, the bloc's president has said.

The "HERA incubator" programme, which begins Wednesday, will bring together the pharmaceutical industry, laboratories, health authorities and researchers, Ursula von der Leyen told French daily Les Echos on Tuesday.

"The virus has evolved and will continue to evolve," said a spokesperson for the bloc -- which has been criticised for its a slow rollout of vaccines so far.

"It is important we prepare for mutations."

Member states will also be asked to contribute additional funds so the EU can adapt and modify contracts already signed with vaccine providers and secure doses against future variants, Bloomberg reported.

The EU Commission did not comment when contacted by AFP.

With delays to deliveries of three already-authorised vaccines by AstraZeneca, Pfizer/BioNTech and Moderna, the EU's medicines regulator is under pressure from European capitals to speed more into service.

US pharmaceutical giant Johnson & Johnson is the latest to apply for authorisation for its coronavirus vaccine in the EU with a decision possible by the middle of March, Europe's drugs regulator said Tuesday.

Comments

Comments are closed.